REFERENCES
- Barry P. W., O'Callaghan C. In vitro comparison of the amount of salbutamol available for inhalation from different formulations used with different spacer devices. Eur. Respir. J. 1997; 10: 1345–1348
- Bowes S. M., Swift D. L. Deposition of inhaled particles in the oral airway during oronasal breathing. Aerosol Sci. Technol. 1989; 11: 157–167
- Brocklebank D., Ram F., Wright J., Barry P., Cates C., Davies L., Douglas G., Muers M., Smith D., White J. Comparison of the effectiveness of inhaler devices in asthma and chronic obstruction airway disease. Health Technol. Assess. 2001; 5(26)1–149
- Chan T. L., Lippmann M. Experimental measurement and empirical modeling of the regional deposition of inhaled particles in human. J. Indep. Hyg. Assoc. 1980; 41: 399–409
- Cheng Y. S., Zhou Y., Chen B. Particle deposition in a cast of human oral airways. Aerosol Sci. Technol. 1999; 31: 286–300
- Cheng Y. S., Fu C. S., Yazzie D., Zhou Y. Respiratory deposition patterns of salbutamol PMDI with CFC and HFA-134a formulation in a human airway replica. J. Aerosol Med. 2001; 14(2)255–266
- Dehaan W., Finlay W. In In vitro monodisperse aerosol deposition in a mouth and throat with six different inhalation devices. J. Aerosol Med. 2001; 14(3)361–367
- Dehaan W., Finlay W. Predicting extrathoracic deposition from dry powder inhalers. J. Aerosol Sci. 2004; 35(3)309–331
- Emmett P. C., Aitken R. J., Hannan W. J. Measurements of total and regional deposition of inhaled particles in the human respiratory tract. J. Aerosol Sci. 1982; 13: 549–560
- Foord N., Black A., Walsh M. Regional deposition of 2.5–7.5 μm diameter inhaled particles in healthy male non-smokers. J. Aerosol Sci. 1978; 9: 283–390
- Grgic B., Finlay W. H., Heenan A. F. Regional aerosol deposition and flow measurements in idealized mouth and throat. J. Aerosol Sci. 2004; 35: 21–23
- Heenan A. F., Finlay W. H., Matida E. A., Pollard A. Experimental measurements and computational modeling of the flow in an idealized extrathoracic airway. Exp. Fluids 2003; 35: 70–84
- Johnson K. Inhalation drug delivery: Principles, techniques and applications to product development. Notes for AAPS Short Course, Miami Beach, FL 1995
- Kim C. S., Garcia L. Delivery characteristics of albuterol powder aerosol by Rotahaler. J. Aerosol Med. 1993; 2: 199–211
- Lipmann M., Albert R. E. The effect of particle size on the regional deposition of inhaled aerosol in the human respiratory tract. J. Indep. Hyg. Assoc. 1969; 30: 257–275
- Lin T., Breysse P., Laube B., Swift D. Mouthpiece diameter affects deposition efficiency in cast models of human oral airway. J. Aerosol Med. 2001; 14(3)335–341
- Newman S. P., Clark A. R., Talaee N., Clarks S. W. Pressurized aerosol deposition in the human lung with and without an “open” spacer device. Thorax 1989; 44: 706–710
- Newmann S. P., Clarke S. W. Editorial. Therapeutic aerosols 1—Physical and practical considerations. Thorax 1983; 38: 881–886
- Newmann S. P. Aerosol deposition considerations in inhalation therapy. Chest 1985; 88: 125–160
- Smyth H. D. C., Hickey A. J. Multimodal particle size distributions emitted from HFA-134a solution pressurized metered-dose inhalers. AAPS PharmSciTech. 2003; 4(3)38
- Stahilofen W., Gebhart J., Heyder J. Experimental determination of the regional deposition of aerosol in the human respiratory tract. J. Indep. Hyg. Assoc. 1980; 41: 385–395
- Stahilofen W., Gebhart J., Heyder J., Scheuch G. New regional deposition date of the human respiratory tract. J. Aerosol Med. 1983; 2: 285–308
- Swift D. L. Design of aerosol delivery system to optimize regional deposition and agent utilization. J. Aerosol Med. 1989; 2: 211–220
- Yu C. P., Diu C. K. Total and regional deposition of inhaled aerosol in humans. J. Aerosol Sci. 1983; 14: 599–609
- Zhang Y., Chia T. L., Finlay W. H. Experimental measurements and numerical study of particle deposition in highly idealized mouth–throat models. Aerosol Sci. Technol. 2006; 40: 361–372